Part Details | USP CLONAZEPAM TABLETS
6505-01-055-5070
Alternate Parts: NDC00228300511, NDC00228-3005-11, 1445389, 6505NCM163282, NDC00093083401, NDC00093-0834-01, NDC00004009801, NDC00004-0098-01, KLONOPIN, NDC00603295021, NDC00603-2950-21, NDC00185006501, NDC00185-0065-01, 6505-01-055-5070, 01-055-5070, 6505010555070, 010555070
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | FEB 07, 1978 | 01-055-5070 | 33952 ( CLONAZEPAM TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-055-5070
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00228-3005-11 | 6LMB8 | ACTAVIS PHARMA, INC. |
| 1445389 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM163282 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00093-0834-01 | 3V9D8 | FULLER SHAWN A |
| NDC00004-0098-01 | 04493 | HOFFMANN-LA ROCHE INC. |
| KLONOPIN | 04493 | HOFFMANN-LA ROCHE INC. |
| NDC00603-2950-21 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
| NDC00185-0065-01 | 0THL4 | SANDOZ INC. |
Technical Data | NSN 6505-01-055-5070
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB2.000 MILLIGRAMS CLONAZEPAM |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| SPECIAL FEATURES | EACH TABLET CONTAINS 2 MG OF CLONAZEPAM IN BOTTLES OF 100 TABLETS; STRENGTH: 2 MG; SCHEDULE IV CONTROLLED SUBSTANCE; STORE AT 20 TO 25 C (68 TO 77 F), ?SEE USP CONTROLLED ROOM TEMPERATURE| |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S |